Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Small Cell Lung Carcinoma × ceralasertib × Clear all

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 SCLC 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Neoplasms 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 High Grade Serous Carcinoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Advanced Solid Malignancies 1

Interventions

Carboplatin 47 Etoposide 45 Cisplatin 42 Topotecan 38 Paclitaxel 20 Irinotecan 20 Nivolumab 14 pembrolizumab 13 Gemcitabine 13 Ipilimumab 11 atezolizumab 10 durvalumab 9 Radiotherapy 9 Doxorubicin 7 Bevacizumab 7 rovalpituzumab tesirine 6 etoposide phosphate 6 amrubicin 6 Psychiatric Rehabilitation 6 Docetaxel 6 Counseling 6 trilaciclib 5 Temozolomide 5 Sunitinib 5 Platinum 5 PM 01183 5 Imatinib Mesylate 5 Cyclophosphamide 5 Bortezomib 5 130-nm albumin-bound paclitaxel 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04361825 2024-01-03

SUKSES-N4

Samsung Medical Center

Phase 2 Completed

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡